Peptomyc Company
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
.png)
.png)
.png)
(Reupload).png)
(Reupload).png)
(Reupload).png)
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Barcelona, Catalonia, Spain
Founded Date:
2014
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
7
Total Funding:
â¬8.5M
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Register and Claim Ownership